Home › NDC Lookup › RxCUI directory › RxCUI 313072

Sodium polystyrene sulfonate 250 MG/ML Oral Suspension — RxCUI 313072

Name: Sodium polystyrene sulfonate 250 MG/ML Oral Suspension (RxCUI 313072)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 313072 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI313072

Official nameSodium polystyrene sulfonate 250 MG/ML Oral Suspension

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known assodium polystyrene sulfonate 15 GM per 60 ML Oral Suspension; sodium polystyrene sulfonate 15 GM in 60 mL Oral or Rectal Suspension; sodium polystyrene sulfonate 30 GM per 120 ML Oral Suspension

FDA products mapped4

Package NDCs mapped7

Reported Medicaid activity (SDUD)11,114 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sodium Polystyrene Sulfonate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Think of it as a tiny sponge that travels through your intestines. It grabs onto extra potassium in your gut and carries it out of your body in your stool — it never actually enter...
What exactly is sodium polystyrene sulfonate doing in my body?
It can take anywhere from several hours to a few days to meaningfully lower your potassium levels — so it's definitely not a quick fix. If your potassium is dangerously high right...
How long does it take to work, and do I need to take it long-term?

📖 Read our full Sodium Polystyrene Sulfonate guide →

🕸️ Concept Web — How Sodium polystyrene sulfonate 250 MG/ML Oral Susp... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Sodium polystyrene sulfonate 250 MG/ML Oral Suspension RxCUI 313072 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Sodium polystyrene sulfonate 56512 IN
Brand names 2

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Kionex 284757 BN
- SPS 1799649 BN
Dose forms 12

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Sodium polystyrene sulfonate Oral Suspension 375287 SCDF
- Sodium polystyrene sulfonate Oral Liquid Product 1159944 SCDG
- Sodium polystyrene sulfonate Oral Product 1159945 SCDG
- Sodium polystyrene sulfonate Oral Suspension [Kionex] 793740 SBDF
- Sodium polystyrene sulfonate Oral Suspension [SPS] 1799651 SBDF
- Kionex Oral Liquid Product 1171401 SBDG
- Kionex Oral Product 1171402 SBDG
- SPS Oral Liquid Product 1799652 SBDG
- +4 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Sodium polystyrene sulfonate 250 MG/ML 316714 SCDC
- Sodium polystyrene sulfonate 250 MG/ML Oral Suspension [Kionex] 793741 SBD
- Sodium polystyrene sulfonate 250 MG/ML Oral Suspension [SPS] 1799654 SBD
- Sodium polystyrene sulfonate 250 MG/ML [Kionex] 793739 SBDC
- Sodium polystyrene sulfonate 250 MG/ML [SPS] 1799650 SBDC

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Sodium polystyrene sulfonate 250 MG/ML SCDC · 316714
Sodium polystyrene sulfonate Oral Suspension SCDF · 375287
Sodium polystyrene sulfonate Oral Liquid Product SCDG · 1159944
Sodium polystyrene sulfonate Oral Product SCDG · 1159945

Brand-Name Concepts

Sodium polystyrene sulfonate 250 MG/ML Oral Suspension [Kionex] SBD · 793741
Sodium polystyrene sulfonate 250 MG/ML Oral Suspension [SPS] SBD · 1799654
Sodium polystyrene sulfonate 250 MG/ML [Kionex] SBDC · 793739
Sodium polystyrene sulfonate 250 MG/ML [SPS] SBDC · 1799650
Sodium polystyrene sulfonate Oral Suspension [Kionex] SBDF · 793740
Sodium polystyrene sulfonate Oral Suspension [SPS] SBDF · 1799651
Kionex Oral Liquid Product SBDG · 1171401
Kionex Oral Product SBDG · 1171402
SPS Oral Liquid Product SBDG · 1799652
SPS Oral Product SBDG · 1799653

📦 FDA Products & Package NDCs

4 products · 7 package NDCs

7 package NDCs map to RxCUI 313072 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
35573-0108-14	10 BOTTLE, UNIT-DOSE in 1 CARTON (35573-108-14) / 60 mL in...	Sodium Polystyrene Sulfonate	Burel Pharmaceuticals, LLC	2025-12-18
35573-0108-57	473 mL in 1 BOTTLE (35573-108-57)	Sodium Polystyrene Sulfonate	Burel Pharmaceuticals, LLC	2026-06-19
46287-0006-01	473 mL in 1 BOTTLE (46287-006-01)	Sodium Polystyrene Sulfonate	CMP Pharma, Inc.	1982-12-08
46287-0006-04	120 mL in 1 BOTTLE (46287-006-04)	Sodium Polystyrene Sulfonate	CMP Pharma, Inc.	1987-07-16
46287-0006-60	10 BOTTLE, UNIT-DOSE in 1 CARTON (46287-006-60) / 60 mL in...	Sodium Polystyrene Sulfonate	CMP Pharma, Inc.	1985-12-12
55154-7353-02	2 BOTTLE, UNIT-DOSE in 1 BAG (55154-7353-2) / 60 mL in 1 BO...	Sodium Polystyrene Sulfonate	Cardinal Health 107, LLC	1983-01-01
62559-0356-01	10 BOTTLE in 1 CASE (62559-356-01) / 60 mL in 1 BOTTLE (625...	Kionex	ANI Pharmaceuticals, Inc.	2024-05-03

Observed labelers: CMP Pharma, Inc. (3) · Burel Pharmaceuticals, LLC (2) · ANI Pharmaceuticals, Inc. (1) · Cardinal Health 107, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.